Literature DB >> 174825

Antibody responses to a combination vaccine against Haemophilus influenzae type b, diphtheria, pertussis, and tetanus.

E R Moxon, P Anderson, D H Smith, T Blanca Adrianzen, G G Graham, R S Baker.   

Abstract

Forty-one children were studied in order to provide information on antibody responses to H. influenzae type b polyribophosphate (PRP), given in combination with diphtheria-pertussis-tetanus vaccine (DPT). When PRP was administered alone, 9 of 15 children demonstrated fourfold or greater increases in titres of anti-PRP antibody. In contrast, in the group receiving a combination vaccine consisting of DPT and PRP only 1 of 13 children showed a similar rise in anti-PRP antibody. It was concluded that, in the population studied, the combination vaccine was less effective than PRP alone. The reasons for this difference and its potential significance are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 174825      PMCID: PMC2366331     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03
  1 in total
  3 in total

Review 1.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

2.  Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.

Authors:  N A Halsey; T L Johansen; L C Bowman; M P Glode
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

3.  Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.

Authors:  C Chu; R Schneerson; J B Robbins; S C Rastogi
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.